These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 36157542)

  • 1. Mechanistic and functional extrapolation of SET and MYND domain-containing protein 2 to pancreatic cancer.
    Alshammari E; Zhang YX; Yang Z
    World J Gastroenterol; 2022 Aug; 28(29):3753-3766. PubMed ID: 36157542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coordination of stress signals by the lysine methyltransferase SMYD2 promotes pancreatic cancer.
    Reynoird N; Mazur PK; Stellfeld T; Flores NM; Lofgren SM; Carlson SM; Brambilla E; Hainaut P; Kaznowska EB; Arrowsmith CH; Khatri P; Stresemann C; Gozani O; Sage J
    Genes Dev; 2016 Apr; 30(7):772-85. PubMed ID: 26988419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical characterization of human SET and MYND domain-containing protein 2 methyltransferase.
    Wu J; Cheung T; Grande C; Ferguson AD; Zhu X; Theriault K; Code E; Birr C; Keen N; Chen H
    Biochemistry; 2011 Jul; 50(29):6488-97. PubMed ID: 21678921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone methyltransferase SMYD2: ubiquitous regulator of disease.
    Yi X; Jiang XJ; Fang ZM
    Clin Epigenetics; 2019 Aug; 11(1):112. PubMed ID: 31370883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tale of two domains: proteomics and genomics analysis of SMYD2, a new histone methyltransferase.
    Abu-Farha M; Lambert JP; Al-Madhoun AS; Elisma F; Skerjanc IS; Figeys D
    Mol Cell Proteomics; 2008 Mar; 7(3):560-72. PubMed ID: 18065756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into the mechanisms driven by H3K4 KMTs in pancreatic cancer.
    LaRue-Nolan KC; Raja Arul GL; Sigafoos AN; Shi J; Fernandez-Zapico ME
    Biochem J; 2024 Aug; 481(15):983-997. PubMed ID: 39078225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic upregulation of MNAT1 by SMYD2 is linked to PI3K/AKT activation and tumorigenesis of pancreatic adenocarcinoma.
    Xu Z; Liu Y; Pan Z; Qin L
    Histol Histopathol; 2024 Feb; 39(2):263-277. PubMed ID: 37232506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural insights into estrogen receptor α methylation by histone methyltransferase SMYD2, a cellular event implicated in estrogen signaling regulation.
    Jiang Y; Trescott L; Holcomb J; Zhang X; Brunzelle J; Sirinupong N; Shi X; Yang Z
    J Mol Biol; 2014 Oct; 426(20):3413-25. PubMed ID: 24594358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformational Dynamics of Lysine Methyltransferase Smyd2. Insights into the Different Substrate Crevice Characteristics of Smyd2 and Smyd3.
    Chandramouli B; Chillemi G
    J Chem Inf Model; 2016 Dec; 56(12):2467-2475. PubMed ID: 27959541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and characterization of Smyd2: a split SET/MYND domain-containing histone H3 lysine 36-specific methyltransferase that interacts with the Sin3 histone deacetylase complex.
    Brown MA; Sims RJ; Gottlieb PD; Tucker PW
    Mol Cancer; 2006 Jun; 5():26. PubMed ID: 16805913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of human lysine methyltransferase Smyd2 reveals insights into the substrate divergence in Smyd proteins.
    Xu S; Zhong C; Zhang T; Ding J
    J Mol Cell Biol; 2011 Oct; 3(5):293-300. PubMed ID: 21724641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of SMYD2-mediated EML4-ALK methylation on the signaling pathway and growth in non-small-cell lung cancer cells.
    Wang R; Deng X; Yoshioka Y; Vougiouklakis T; Park JH; Suzuki T; Dohmae N; Ueda K; Hamamoto R; Nakamura Y
    Cancer Sci; 2017 Jun; 108(6):1203-1209. PubMed ID: 28370702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting SMYD2 inhibits angiogenesis and increases the efficiency of apatinib by suppressing EGFL7 in colorectal cancer.
    Zhang Y; Zhou L; Xu Y; Zhou J; Jiang T; Wang J; Li C; Sun X; Song H; Song J
    Angiogenesis; 2023 Feb; 26(1):1-18. PubMed ID: 35503397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of SET and MYND domain-containing protein 2 (
    Zhang P; Ruan J; Weng W; Tang Y
    Leuk Lymphoma; 2020 Feb; 61(2):437-444. PubMed ID: 31612757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central role of Yes-associated protein and WW-domain-containing transcriptional co-activator with PDZ-binding motif in pancreatic cancer development.
    Rozengurt E; Eibl G
    World J Gastroenterol; 2019 Apr; 25(15):1797-1816. PubMed ID: 31057295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of EZH2 by SMYD2-Mediated Lysine Methylation Is Implicated in Tumorigenesis.
    Zeng Y; Qiu R; Yang Y; Gao T; Zheng Y; Huang W; Gao J; Zhang K; Liu R; Wang S; Hou Y; Yu W; Leng S; Feng D; Liu W; Zhang X; Wang Y
    Cell Rep; 2019 Nov; 29(6):1482-1498.e4. PubMed ID: 31693890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SETD8 potentiates constitutive ERK1/2 activation via epigenetically silencing DUSP10 expression in pancreatic cancer.
    Liu M; Qin Y; Hu Q; Liu W; Ji S; Xu W; Fan G; Ye Z; Zhang Z; Xu X; Yu X; Zhuo Q
    Cancer Lett; 2021 Feb; 499():265-278. PubMed ID: 33232789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenic ERBB2 aberrations and KRAS mutations cooperate to promote pancreatic ductal adenocarcinoma progression.
    Li Z; Shao C; Liu X; Lu X; Jia X; Zheng X; Wang S; Zhu L; Li K; Pang Y; Xie F; Lu Y; Wang Y
    Carcinogenesis; 2020 Mar; 41(1):44-55. PubMed ID: 31046123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ectopic HOTTIP expression induces noncanonical transactivation pathways to promote growth and invasiveness in pancreatic ductal adenocarcinoma.
    Wong CH; Li CH; He Q; Chan SL; Tong JH; To KF; Lin LZ; Chen Y
    Cancer Lett; 2020 May; 477():1-9. PubMed ID: 32120024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysine methyltransferase SMYD2 promotes triple negative breast cancer progression.
    Li LX; Zhou JX; Calvet JP; Godwin AK; Jensen RA; Li X
    Cell Death Dis; 2018 Feb; 9(3):326. PubMed ID: 29487338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.